Tag: chief scientific officer

April 13, 2018

Maricann Group Announces Definitive Agreement for Haxxon Acquisition

Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCMKTS:MRRCF) (“Maricann” or “the Company”) is pleased to announce it has entered into a definitive...
April 12, 2018

Growing Research Efforts Provide Benefits in the Cannabis Industry

The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before.
April 12, 2018

Tetra Bio-Pharma Gives Report on Cannabis Oil Capsules

Tetra Bio-Pharma gave shareholders an update on the encapsulated cannabis oils (PPP005) trials and the proposed product availability.
April 4, 2018

Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events

Amarin Corporation (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today...
March 28, 2018

Actinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actinium’s AWE Platform Technology

Actinium Pharmaceuticals (NYSE:ATNM) announced that it has entered into a research and option agreement with Astellas Pharma to develop Actinium-225 Radio-Conjugates...
March 28, 2018

Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962

Edge Therapeutics (Nasdaq:EDGE) announced that a pre-specified interim analysis performed on data from the Day 90 visit of the first...
March 26, 2018

Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions

Organovo (NASDAQ:ONVO) announced that its wholly-owned subsidiary, Samsara Sciences, a provider of highly specialized human liver cells, entered a non-exclusive...